This firm offers profit splits that potentially reach up to 100%. Generally, few prop firms will go this far. It’s an enticing element that may speak to BrightFunded’s trader-first approach.

Ousia Pharma logo Omega Funds Logo . Pioneering a first-in-class drug-targeting approach that leverages hormone analogues to deliver small-molecule neuroplas ...

Lawyers, as guardians of justice and the rule of law, represent a significant barrier to those who seek to impose tyranny or ...

The court previously denied the defendant’s CPLR 3211 motion to dismiss the amended complaint. The defendant asserted counterclaims for breach of contract against the co-op and alleged “breach of ...

No one in politics today has lived through a first 100 days like the one Donald ... thing to me has been Trump’s targeting of large law firms with executive orders, which then led to a bunch ...

“We executed a complex restructuring to acquire the Pelthos assets, incubated the technology that became ZELSUVMI, achieved FDA approval for this first-in-class medication ... across global markets.

At the company's recent Direct Connect conference, however, the new CEO made it clear that not only does Intel have no ...

About JEGI CLARITYJEGI CLARITY is a pre-eminent M&A advisory firm for the media, events, marketing, information and ...

GuRu Wireless, Inc., the company making adaptive, long-range wireless energy transfer possible, announces it will participate in SOF Week 2025 in Tampa, Florida, May 5-8, 2025. SOF (Special Operations ...

Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced the Company has secured multiple market access ...

Co-Founder, Dr. Noa Shelach, to Continue with Lutris Pharma as Chief Operating Officer in Newly Established Role TEL AVIV, Israel, April 29, 2025 /PRNewswire/ -- Lutris Pharma, a clinical ...